Valentine Charlton-Menys1, Yifen Liu, Paul N Durrington. 1. Division of Cardiovascular and Endocrine Sciences, Department of Medicine, Manchester Royal Infirmary, Manchester, United Kingdom. valentine.menys@cmmc.nhs.uk
Abstract
BACKGROUND: Serum paraoxonase (PON1) is an enzyme associated with HDL, and its ability to protect LDL from oxidation is one mechanism by which HDL protects against atherosclerosis. Low concentrations of PON1 are found in patients with type 2 diabetes or coronary heart disease. Serum PON1 activity may also be important in avoidance of organophosphate toxicity in industry. METHODS: The generally accepted method for determining PON1 activity requires use of a recording spectrophotometer and is not suited to large numbers of samples; in addition, automation presents particular problems because of the extreme toxicity of substrates such as paraoxon. We established a relatively safe microtiter plate method that facilitates the determination of PON1 activity at a rate of 120 samples per hour. RESULTS: PON1 activity was determined by the generally accepted method (x) and the new method (y); results correlated with a slope close to unity (y = 0.93x + 8; r = 0.97; P < 0.0001; n = 101). Examination of differences by Bland-Altman plots showed a weak concentration-dependent difference (r = 0.33; P < 0.0001; n = 101). The intra- and interassay sample CVs, obtained with samples with PON1 activities ranging from 41 to 348 nmol x min(-1) x mL(-1), were 3.5% and 2.7%, respectively (n = 16). CONCLUSION: The proposed method for determination of PON1 activity is simple, relatively safe, and inexpensive and is suitable for analysis of large numbers of samples.
BACKGROUND: Serum paraoxonase (PON1) is an enzyme associated with HDL, and its ability to protect LDL from oxidation is one mechanism by which HDL protects against atherosclerosis. Low concentrations of PON1 are found in patients with type 2 diabetes or coronary heart disease. Serum PON1 activity may also be important in avoidance of organophosphatetoxicity in industry. METHODS: The generally accepted method for determining PON1 activity requires use of a recording spectrophotometer and is not suited to large numbers of samples; in addition, automation presents particular problems because of the extreme toxicity of substrates such as paraoxon. We established a relatively safe microtiter plate method that facilitates the determination of PON1 activity at a rate of 120 samples per hour. RESULTS:PON1 activity was determined by the generally accepted method (x) and the new method (y); results correlated with a slope close to unity (y = 0.93x + 8; r = 0.97; P < 0.0001; n = 101). Examination of differences by Bland-Altman plots showed a weak concentration-dependent difference (r = 0.33; P < 0.0001; n = 101). The intra- and interassay sample CVs, obtained with samples with PON1 activities ranging from 41 to 348 nmol x min(-1) x mL(-1), were 3.5% and 2.7%, respectively (n = 16). CONCLUSION: The proposed method for determination of PON1 activity is simple, relatively safe, and inexpensive and is suitable for analysis of large numbers of samples.
Authors: D Estrada-Luna; E Martínez-Hinojosa; J C Cancino-Diaz; H Belefant-Miller; G López-Rodríguez; G Betanzos-Cabrera Journal: Eur J Nutr Date: 2017-02-27 Impact factor: 5.614
Authors: Julie M Proudfoot; Anne E Barden; Wai Mun Loke; Kevin D Croft; Ian B Puddey; Trevor A Mori Journal: J Lipid Res Date: 2008-12-02 Impact factor: 5.922
Authors: Shazli Azmi; Maryam Ferdousi; Yifen Liu; Safwaan Adam; Tarza Siahmansur; Georgios Ponirakis; Andrew Marshall; Ioannis N Petropoulos; Jan Hoong Ho; Akheel A Syed; John M Gibson; Basil J Ammori; Paul N Durrington; Rayaz A Malik; Handrean Soran Journal: Sci Rep Date: 2021-06-15 Impact factor: 4.379